Ide-cel Significantly Prolongs PFS in KarMMa-3 Trial for Multiple Myeloma
Paula Rodriguez-Otero, MD, PhD, provides an overview of the phase 3 KarMMa-3 trial of idecabtagene vicleucel for the treatment of adult patients with relapsed and refractory multiple myeloma.
PERSEUS Supports D-VRd Followed by DR Maintenance as New SOC in MM
Paula Rodriguez-Otero, MD, PhD, discusses the promising results from the phase 3 PERSEUS trial in patients with newly diagnosed, transplant-eligible multiple myeloma.